Msubaroda.ac.in

Bio Data : Prof. (Dr.) Ambikanandan Misra
Name : Dr. Ambikanandan Rajnarayan Misra
Qualification : M.Pharm (Pharmaceutics), Ph.D. (Pharmacy)
Designation : Head, Pharmacy Department,
Faculty of Technology and Engineering, Kalabhavan, The Maharaja Sayajirao University of Baroda, Date of Birth : 15-11-1955
Address Office: Pharmacy Department, Faculty of Technology and Engineering,
The Maharaja Sayajirao University of Baroda, Kalabhavan, Vadodara – 390001, Gujarat state, India Ph. No. +91 265 2434187, 2794051 Residence:Sai-
Samarpan”
E-57, Gokuldham Society, Behind Union Bank, Sama, Baroda – 390008, Gujarat state , INDIA. EDUCATIONAL QUALIFICATION
OF YEAR OF NAME
THE CLASS/ % OF
EXAMINATION
UNIVERSITY
MADHYA PRADESH (M.P.), 1st / 69.84 %INDIA
RESEARCH EXPERIENCE
Research Experience
: 28 years (11 years in Industry & 17 in Academic) Teaching Experience
I NDUSTRIAL EXPERIENCE
1. Scientist, Formulation Development Division, Sarabhai Research Center,
Wadi-wadi, Baroda 390007, Gujarat, INDIA (18th Dec. 1979 - 30th Sep.
1985)

2. Asst. Manager, Quality Control, Sarabhai Chemicals, Wadi-wadi, Baroda
390007 Gujarat, INDIA (1st Oct. 1985 – 11th Aug. 1988)
3. Manager, New Drug Delivery Development, Food and Cosmetic Product
Development, Cadila Laboratories Ltd., 244, Ghodashar, Maninagar, Ahmedabad -380050, Gujarat, INDIA (12th Aug. 1988 – 17th Jan. 1990)
CADEMIC E
XPERIENCE
1. Reader in Pharmaceutical Technology, Pharmacy Department, Faculty of
Technology and Engineering, M.S.University of Baroda, Kalabhavan, Baroda –
390001, Gujarat, INDIA. (18th Jan. 1990 – 25th Apr. 1996)
2. Professor of Pharmaceutics, Pharmacy Department, Faculty of Technology
and Engineering, M.S.University of Baroda, Kalabhavan, Baroda – 390001, Gujarat, INDIA. (26th Apr. 1996 – onwards)
3. Head, Pharmacy Department, Faculty of Technology and Engineering, The
M. S. university of Baroda, Vadodara, Gujarat, India (2003 Onward)
4. Coordinator, TIFAC-CORE in NDDS, Pharmacy Department, Faculty of
Technology and Engineering, The M. S. university of Baroda, Vadodara,
Gujarat, India (2005-Onwards).
5. Dy. Coordinator, Department Research Scheme, Special assistance
program Phase I, University Grant Commission, New Delhi (2002 Onward).
ACADEMIC ACHIEVEMENTS
HONORS & AWARDS
1. Gold Medal (1977) Sagar University, Madhya Pradesh (M.P.), India,
2. Gold Medal (1978) Indian Drug Manufacturer’s Association G.P. Nayar, India
3. Won second prize in National Essay competitions on “Advances in Technology of
Industrial Pharmacy” (1987)
4. Member, Faculty of Technology and Engineering, M.S.University of Bardoa, India
(1990 onwards)
5. Member, Designing a Model Syllabus for M.Pharm. Courses (Pharmaceutics) All
India Council of Technical Education, India.
6. Member of team of inspectors of Pharmacy Council of India, India and All
India Council of Technical Education, India (1993 onwards).
7. Panel of referees 3 International Journals (American Association of
Pharmaceutical Sciences, PharmSci Tech and Pharm. Sci., and Medical Science Monitor) (2000 onwards)
8. Member, Board of Studies, Pharmacy Dept., M.S.University of Baroda, India
(1990 onwards) and Dr. H.S. Gour University, Sagar, M.P., India (July 2002 –
June 2005)
9. AICTE member on Board of Trusties of S.K. Patel College of Pharmacy,
Mehsana, Gujarat, India and S.N. Nahata College of Pharmacy, Mandsur, M.P. India (2002 onwards).
10.Best AICTE TAPTEC Project Award for the research work entitled
“Development of Liposomal Dry Powder Inhaler (DPI) formulations” by Shri.
Bhairon Singh Shekhawat, Vice President of India, on the occasion of
National Awards Function on Technology Day, India (2003)
11.Nominated as a member of Scientific Service Committee, Indian
Pharmaceutical Congress, India for period of three years started from 2004
(2004 -2006).

12.President,Indian Pharmaceutical Association, Vadodara branch, Gujarat, India
13.2008 “Outstanding Manuscript Award” published in AAPS PharmSciTech
(2006-2008)“Preliminary Brain-targeting Studies on Intranasal Mucoadhesive Microemulsions of Sumatriptan. awarded by American “Association of
Pharmaceutical Scientists
” conferred on November 16, 2008 at Atlanta,
GOVERNMENT RESEARCH PROJECTS
1. Principal Investigator, All India Council of Technical Education’s TAPTEC Major
Research Project (15.5 lakhs) 2000. “Development of Liposomal Dry Powder 2. Principal Investigator in All India Council of Technical Education’s Major Research
Project (11.5 lakhs). “Enhanced Pulmonary Bioavailability of Therapeutics by 3. Co-investigator in All India Council of Technical Education’s TAPTEC Major
Research Project (10 lakhs) 1995. “Improvement in Therapeutic Efficacy of
Anti-Malarial Drugs”
4. UGC Minor Research Projects (Rs. 14000), 1990. “Modified Indian gums as
hydrophilic matrices for minor controlled oral delivery”
5. UGC Major Research Projects (Rs. 4.23 lakhs), 2004. “Transmucosal drug
permeation studies using epithelial/endothelial cell lines”
6. Dy. Coordinator, Department Research Scheme (50 lakhs + 50 lakhs),
(Phase 1 + 2) UGC (2002 onwards).
7. Coordinator, Technology Information Forecasting and Assessment
Council’s Centre of Relevance and Excellence in New Drug Delivery
systems (TIFAC-CORE in NDDS), Mission Reach, Department of Science and
Technology, New Delhi, India. Research grant of 2.25 crores.
8. Coordinator, Technology Information Forecasting and Assessment
Council’s Centre of Relevance and Excellence in New Drug Delivery
systems (TIFAC-CORE in NDDS), Mission Reach, Department of Science and
Technology, New Delhi, India. Research grant of 400 lakhs (2007 – 2008).
INDUSTRIAL CONSULTANCIES RESEARCH PROJECTS - 10
Study of the effect of ternary Sun Pharma mixtures & particle morphology on Advanced the fine particle fraction of Research Centre salbutramol sulphate.
RESEARCH ACHIEVEMENTS
Ph.D. Guidance:
Completed: 15
Submitted: 4 (Synopsis)
Presently working: 8
M.Pharm. Projects Guidance: Completed: 41

Presently working: 6
DETAILS OF PUBLICATION
a) No. Of Papers Published: 88
b) Patents Filed: 16
c) Conferences/Presentations: 40
d) No. of Book Chapters Published: Total 11
PATENTS FILED
Sr. Inventors
Tile of patent
Date of Patent
office no.
Nabros Pharma Process of preparing stable 11/11/20 phospholipids formation in injectable 05(Date Misra,Tushar K Microemulsions For Brain Targeted 2004 Sedatives Loaded Intranasal 20th Oct, 1124/MUM Misra,Tushar K Nasoadhesive Microemulsions For 2004 Misra,Tushar K Nasoadhesive Microemulsions For 2004 Misra, Bijay Powders for Effective Treatment of 25th Feb, Kumar Padhi, Lung Diseases.
A process for synthesis of oxidized 26th T. Guargum for use as disitrigrants.
A process for modified technique of 26th T. chemical synthesis of Carboxymethyl March, – Guargum for aqueous film coating 2005 Misra, Mahavir Therapeutic Index of Drugs from Dry 2005 Aerodynamically light porous dry 30th June, 953/MUM/ Misra, Mahavir powder inhaler formulations for 2006 ATIONAL AND INTERNATIONAL P
APERS PUBLISHED
NATIONAL:
1. A.N. Misra, K.C. Verma, N.K. Jain, Dissolution Rate Enhancement of
Chlorpropamide & Tolbutamide By Crystallization, Indian J. Pharm. Sci., 45, 2. N.K. Jain, A.N. Misra, Sustained Release Tablets of Tetracycline Hydrochloride-
In-vivo Evaluation, Indian J. Pharm. Sci., 47, 148-150 (1985).
3. N.K.Jain, A.N.Misra, Controlled Release Tablets Of Hydralazine Hydrochloride,
Indian J. Pharm. Sci, .48, 8-12 (1986) 4. N.K. Jain, A.N.Misra, Controlled Release Beads of hydralazine hydrochloride,
Indian Drugs, 24, 146-149 (1988).
5. V.U. Rao, A.N. Misra, A Comparitive Evaluation Of The Effect Of Penetration
Enhancer on Passive Diffusion and Intophoretic Transport of Insulin, Indian Drugs, 32, 437-441 (1994).
6. V.U. Rao, A.N. Misra, Transdermal Administration: Effect of Various Penetration
Enhances, Indian J. Of Exp. Biol., 34, 171-773 (1996) 7. J.M. Baweja, A.N. Misra, Studies on Kinetics of Drug Release from Modified Guar
Gum Matrix, Indian J. Pharm. Sci., 59, 316-320 (1997).
8. J.M.Baweja, A.N.Misra, Modified Guar Gum as Hydrophilic Matrix for Controlled
Release Tablets, Indian Drugs, 34, 216-223 (1997).
9. A.B. Rao, A.N.Misra, Modification of Lactose for Direct Compression-I, Indian J.
Pharm. Sci., 16, 79-89 (1998).
10. M.R. Lad, A.N. Misra, V.B. Patel, Effect of Current on Dermal Permeation of
Positively Charged Liposomes, Indian J. Exp. Biol., 36, 578-582 (1998).
11. A.B. Rao, A.N.Misra, Modification of Lactose for Direct Compression II, Indian J.
Pharm. Sci., 61, 231-236 (1999).
12. M.R. Joshi, A.N.Misra, Liposomes of terbutaline sulphate: In vitro and in vivo
studies, Indian J. of Exp. Biol., 37(9), 881-887 (1999). 13. M.R. Joshi, A.N. Misra, Liposomes of terbutaline sulfate: Preparation,
Optimization and Stability Studies, Indian Drugs, 36, 689-697 (1999).
14. M.R. Joshi, A.N. Misra, Spectrophotometric Determination of Budesonide, Indian
J. Pharm. Sci., 62, 92-96 (2000).
15. Avinash Sheth, Ambikanandan Misra, Enhancement of liposomal stability by
adsorption of cross-linked Bovine Serum Albumin, Indian Drugs, 39, 474-480 16. Joshi M.R., S.P. Shah and A.N. Misra. Preparation and Evaluation of Directly
Compressible Forms of Rifampicin and Ibuprofen. Indian J. Pharm. Sci., 65(3): 232-238, (2003).
17. S. P. Shah, S. Ganesh and A. N. Misra. Factors Affecting Development of Dry
Powder Inhalers. Indian J. Pharm. Sci., 65(4): 336-345, (2003).
18. Ambikanandan Misra, Transdermal Drug Delivery: Present and Future. The
Pharma Review, Vol. II, No.11, (2004).
19. Mayur Kalariya, Bijay Kumar Padhi, Mahavir Chougule, Ambikanandan Misra
Incorporation of Clobetasol Propionate in Solid Lipid Nanoparticles for Treatment of Eczema: Formulation and Clinical Implications, Indian Journal of Experimental Biology, 43, 233-240, March (2005).
20. A. K. Seth and A. N. Misra, Preparation and optimization of Idoxuridine
liposomes, Indian Journal of pharmaceutical Sciences, 67(1): 89-95, (2005).
21. Ambikanandan Misra, Possible Impact of TRIPS on Indian Health Care System.
The Pharma Review, 4(19), 25- , Dec (2005).
22. Misra, Ambikanandan, “Intranasal drug delivery for CNS Disorders” Cronicle
Pharmabiz, 93-102, November 30, (2006).
23. Misra, Ambikanandan, “NDD Research: Need Or Compulsion?” Cronicle
Pharmabiz, 103-105, November 30, (2006).
24. Misra, Ambikanandan, “Intranasal Drug Delivery for Central Nervous System
Disorders” The Pharma Review, 101-106, December (2006).
25. Misra, Ambikanandan, Dry powder inhalers: Novel Approaches, Pharmabiz,
26. Misra, Ambikanandan Drug delivery to brain: Emerging potential, Pharmabiz,
27. Mahesh Balaria, Sachin Naik, Ambikanandan Misra, Ethosomes: A Novel Drug
Delivery Systems of Antifugal Drugs in Treatment of Topical Fungal Diseases, Indian Journal of Experimental Biology, Accepted. INTERNATIONAL:
28. N.K. Jain, A.N. Misra, Controlled Release Capsule Of Tetracycline HCl, Drug
Dev. Ind. Pharm., 15, 825-844 (1989).
29. V.U. Rao, A.N. Misra, Effect of Penetration Enhances on Transdermal Absorption
of Insulin across Human Cadaver Skin, Drug Dev. Ind. Pharm., 20, 258-259 30. V.U. Rao, A.N. Misra, Enhancement of Iontophoretic Permeation of Insulin
across Human Cadaver Skin, Pharmazie, 49, 538-539 (1997).
31. J.M. Baweja, A.N.Misra, Modified Guar Gum As a Tablet Disintegrant,
32. V.B. Patel, A.N. Misra and Y.S. Marfatia, Topical Dosage Form of Lipsomes
Clofazimine Research and Clinical Implications, Pharmazie, 54, 448-451 (1999).
33. J.M. Baweja, A.N.Misra, Modified Guar Gum as a Film Former, Pharmazie, 54,
34. V.B. Patel, A.N.Misra, Encapsulation and Stability of Clofazimine Liposomes, J.
Microencap., 16, 357-367 (1999).
35. V.B. Patel, A.N. Misra and Y.S. Marfatia, Topical Liposomal Gel of Tretnoin for
the treatment of Acne: Research and Clinical Implications, Pharm. Dev. Tech., 5, 455-464 (2000). 36. V.B. Patel, A.N.Misra and Y.S. Marfatia, Preparation and Comparative Clinical
Evaluation of Liposomal gel of Benzoyl Peroxide for Acne, Drug. Dev. Ind. Pharm., 27 (8), 863 – 869, (2001).
37. M. R. Joshi and A.N. Misra, DPI of Liposomal Ketotifen Fumarate: Formulation
and Characterization, Int. J. Pharmaceutics, 223(1-2): 15-27 (2001). 38. V.B. Patel, A.N. Misra and Y.S. Marfatia, Clinical assessment of the combination
therapy with liposomal gels of tretinoin and benzoyl peroxide in acne, AAPS PharmSciTech, 2(3) Technical Note 3, (2001).
39. M. R. Joshi and A.N. Misra, Liposomal Budesonide for Dry Powder Inhaler:
Preparation and Stabilization AAPS PharmSciTech, 2(4), article 25, (2001).
40. M. R. Joshi and A.N. Misra, Pulmonary disposition of budesonide from liposomal
dry powder inhaler, Methods Find Exp Clin Pharmacol, 23(10): 531-536, (2001).
41. A. Shahiwala and A.N. Misra. Studies in topical application of niosomally
entrapped Nimesulide. J. Pharm. Pharmaceut. Sci., 5(3): 220-225, (2002).
42. A.K. Seth and A.N. Misra. Mathematical Modeling of preparation of acyclovir
liposomes: reverse phase evaporation method. J. Pharm. Pharmaceut. Sci., 43. M.R. Joshi and A.N.Misra. Disposition kinetics of ketotifen from liposomal dry
powder for inhalation in rat lung. Clin. Exp. Pharmaco. Physio., 30(3): 153- 156, (2003) 44. A.K. Seth, A.N. Misra and D. Umrigar. Role of novel acyclovir gel in herpes
simplex: A clinical implication. Medical Sci. Monitor., 9(7): 193-198, (2003) 45. A.N. Misra and T. Mahesh, Influence of Absorption Promoters on Pulmonary
Insulin Bioactivity, AAPS PharmSciTech., 4(2): article 15, (2003).
46. Ambikanandan Misra, Ganesh S., Aliasgar Shaiwala, Shrenik P. Shah, Drug
Delivery to the Central Nervous System: A review. J. Pharm. Pharmaceut. Sci., 47. Avinash Kumar Seth; Ambikanandan Misra; Dipak Umrigar, Topical Liposomal
Gel of Idoxuridine for the Treatment of Herpes Simplex: Pharmaceutical and Clinical Implications, Pharm. Dev. Technol., 9(3) 277 – 289, (2004).
48. Shah S.P. and Misra Ambikanandan, Development of Liposomal Amphotericin B
Dry Powder Inhaler Formulation, Drug delivery, 11(4), 247-253, (2004).
49. Mayur Kalariya, Bijay Kumar Padhi, Mahavir Chougule, Methotrexate Loaded
Solid Lipid Nanoparticles for Topical Treatment of Psoriasis: Formulation and Clinical Implications, Drug delivery Technology, 4(8), Oct. (2004).
50. Shahiwala A. and Misra Ambikanandan, Pulmonary absorption of liposomal
Levonorgesterel, AAPS PharmSciTech, 5(1), article 13, (2004).
51. Shrenik P. Shah and Ambikanandan Misra, Liposomal Amikacin Dry Powder
Inhaler: Effect of Fines on In Vitro Performance, AAPS PharmSciTech, 5(4), article 65, (2004).
52. T. Mahesh Kumar and Misra Ambikanandan, Pulmonary Absorption
Enhancement of Salmon Calcitonin, Journal of Drug Targeting, 12(3), 135 – 144, (2004).
53. Shah, S. P.; Misra, Ambikanandan, Liposomal Amphotericin B dry powder
inhaler: Effect of fines on in vitro performance, Pharmazie, 59(10), 812-813, 54. Shahiwala A. and Misra Ambikanandan, Nasal delivery of Levonorgesterel for
contraception – an experimental study in rats, Fertility and Sterility, 81, 893-898, (2004). 55. Aliasgar Shahiwala and Ambikanandan Misra, Nasal Delivery of liposomal
leuprolide acetate for contraception. Drug Delivery Technology, (Feb 2005).
56. Aliasgar Shahiwala and Ambikanandan Misra, A preliminary pharmacokinetic
study of liposomal leuprolide dry powder inhaler: a technical note.
AAPS PharmSciTech, 6(3): E482 – 486, (2005).
57. Tushar k.Vyas, Aliasgar sahiwala, Sudhanva Marathe and Ambikanandan Misra,
Intranasal Drug Delivery for Brain Targeting. Current drug Delivery, 2, 165 – 58. Sachin Naik, Mahavir Chougule, Bijay Kumar padhi, Ambikanandan Misra,
Development of novel lyophilized mixed micelle Amphotericin B formulation for treatment of systemic fungal infection, Current drug Delivery, 2, 177 – 184, 59. Tushar K. Vyas, A.K. Babbar, R.K. Sharma, and Ambikanandan Misra,
Intranasal mucoadhesive microemulsion of zolmitriptan: Preliminary studies on brain-targeting. Journal of Drug Targeting, 13(5):317 – 324, (2005).
60. Tushar K. Vyas, A.K. Babbar, R.K. Sharma, Shashi Singh and Ambikanandan
Misra, Preliminary Brain Targeting Studies of Intranasal Mucoadhesive Microemulsions of Sumatriptan. AAPS PharmSciTech, 7(1), Article 8, (2006).
61. Tushar K. Vyas, A.K. Babbar, R.K. Sharma, Shashi Singh and Ambikanandan
Misra, Intranasal Mucoadhesive Microemulsions of Clonazepam: Preliminary Studies on Brain Targeting. J Pharm Sci., 95(3):570 – 580, (2006).
62. Aliasgar Shahiwala and Ambikanandan Misra, Preliminary investigation of the
nasal delivery of liposomal leuprolide acetate for contraception in rats, J Pharm Pharmacol., 58(1): 19 – 26, (2006).
63. Shah P, Jogani V, Bagchi T, Misra A., Role of Caco-2 Cell Monolayers in
Prediction of Intestinal Drug Absorption, Biotechnol Prog., 22(1): 186 – 198, (2006).
64. Mahavir B. Chougule, Bijay kumar Padhi, Ambikanandan Misra, Nano-liposomal
Dry Powder Inhaler of Amiloride Hydrochloride. Journal of Nanoscience and Nanotechnology, Vol. 6 (9-10), 3001–3009, (2006). 65. T. Mahesh Kumar and Ambikanandan Misra, Formulation and Evaluation of
Insulin Dry Powder for Inhalation, Drug Development and Industrial pharmacy, 32 (6), 677-686, (2006).
66. Bijay K Padhi, Mahavir B. Chougule, Ambikanandan Misra, “Optimization of
formulation components and characterization of large respirable powders containing high therapeutic payload”, Pharmaceutical Development Technology, 67. Mahavir B. Chougule, Bijay K. Padhi, Kaustubh A. Jinturkar and Ambikanandan
Misra, “Development of Dry Powder Inhalers” Recent Patents on Drug Delivery & Formulation, 1, 11-21, (2007).
68. Mahavir B. Chougule, Bijay K. Padhi, and Ambikanandan Misra, Nano- liposomal
dry powder inhaler of tacrolimus: preparation, characterization and pulmonary pharmacokinetics, International Journal of Nanomedicine, 2(4):675-88 (2007) 69. Pritam Kanagale, Braj Bhushan Lohray, Prakash Davadra, Rajesh Kini and
Ambikanandan Misra, Formulation and Optimization of Porous Osmotic Pump Based Controlled Release System of Oxybutynin, AAPS PharmSciTech., 70. Avinash Kumar Seth and Ambikanandan Misra, Preparation and Evaluation of
Acyclovir Liposomes by Two Techniques: A Comparative Study, Iranian Journal of Pharmaceutical Reseach, 6 (2): 75-81(2007).
71. Naazneen Surti, Sachin Naik, and Ambikanandan Misra, Assessment of in-
vitro antiproliferative activity of WGA-conjugated budesonide nanoparticles in A-549 cells, Journal of Biomedical Nanotechnology, Vol 3, (2007).
72. Ambikanandan Misra, Pranav Shah, Viral Jogani, P. Mishra, A.K. Mishra, and T.
Bagchi Role of 99mTc-Mannitol and 99mTc-PEG in Assessment of Paracellular Integrity of Cell Monolayers, Nuclear Medicine Communications, 28(8):653-9, (2007) 73. Jogani Viral, Shah PJ, Mishra P, Mishra AK, Misra AN, Nose to Brain Delivery of
Tacrine , Journal of Pharmacy and Pharmacology, 59(9):1199-205, (2007) 74. Ambikanandan Misra, Pranav Shah, Viral Jogani, P. Mishra, A.K. Mishra, and T.
Bagchi Modulation of Ganciclovir Intestinal Absorption in Presence of Absorption Enhancers .Journal of Pharmaceutical Sciences, 96(10):2710-22. (2007) 75. Jogani Viral, Shah PJ, Mishra P, Mishra AK, Misra AN, Intranasal Mucoadhesive
Microemulsion of Tacrine to Improve Brain Targeting, Alzheimer Disease and Associated Disorders, 22 (2), 116-124 , (2008).
76. Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K., Intranasal
nanoemulsion based brain targeting drug delivery system of risperidone., Int J 78. Nazneen Surti, Ambikanandan Misra, Intracellular Delivery of Nanoparticles of
an Antiasthmatic Drug, AAPS PharmSciTech 9(1):217-23. (2008) 79. Bijay Padhi, Mahavir Chougule, Ambikanandan Misra, Development of Spray
Dried Liposomal Dry Powder Inhaler of Dapsone, AAPS PharmSciTech, 80. Ambikanandan Misra, Pranav Shah, Viral Jogani, P. Mishra, A.K. Mishra, and T.
Bagchi In Vitro Assessment of Transepithelial Permeation of Acyclovir in presence of Absorption Enhancers, Drug Development and Industrial Pharmacy, 81. Nazneen Surti, Ambikanandan Misra Wheat Germ Agglutinin Conjugated
nanoparticles For Sustained Cellular And Lung Delivery of Budesonide, Drug Deliv., 15(2):81-6. (2008) 82. Viral Jogani, Kaustubh Jinturkar, Tushar Vyas and Ambikanandan Misra Recent
Patents Review on Intranasal Administration for CNS Drug Delivery, Recent Patents on Drug Delivery & Formulation, 2 (1), 25-40, (2008) 84. Padhi Bijay, Chougule Mahavir, Misra Ambikanandan. "Aerosol Performance of
Large Respirable Particles of Amikacin Sulfate Produced by Spray and Freeze Drying Techniques", Current Drug Delivery, In press. Vol. 6, Isuue 1, January 2009 85. Naazneen Surti, Sachin Naik, Ambikanandan Misra. Pharmacokinetic Evaluation
of Wheat Germ Agglutinin-Grafted Nanoparticles of Mometasone Furoate Sci Pharm.; in press. doi:10.3797/scipharm.0803-13 86. Ambikanandan Misra, Kaustubh Jinturkar, Deepa Patel, Jigar Lalani & Mahavir
Chougule. Recent advances in liposomal dry powder formulations: preparation and evaluation. Expert Opin. Drug Deliv. (2009) 6 (1):1-19 87. Mukesh Kumar; Ambikanandan Misra; A. K. Mishra; Pushpa Mishra; Kamla
Pathak. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. Journal of Drug Targeting, December 2008; 16(10): 806–814 88.Mukesh Kumar; Ambikanandan Misra. Nanoemulsion Based Drug Delivery
System Of Olanzapine For Brain Targeting Formulation Considerations. PDA Journal of Pharmaceutical sciences and Technology.
Papers Accepted for Publication:
89. Ambikanandan Misra, Sheetal Porecha, Tapan Shah, Viral Jogani, Sachin Naik,
Microemulsion Based Transnasal drug delivery for treatment of insomnia, Drug Delivery , Accepted on 17-10-2008. Papers in Communication:
90.Gitanjali Sharma, Ambikanandan Misra. "Role Of Intranasal Cabergoline In
Obesity Management,". AAPS Pharm Sci Tech .2009.(communicated) BOOKS PUBLISHED:
1. A.N.Misra, Transdermal Drug Delivery’ In “Controlled and Novel Drug Delivery
(Ed. N. K. Jain)”, CBS Publications, New Delhi - 1997
2. A.N.Misra, “Advances in Pulmonary Drug Delivery” In “Advances in Controlled and
Novel Drug Delivery (Ed. N. K. Jain)”, CBS Publications, New Delhi – 2000 3. A.N.Misra, “Liposomal Transdermal Delivery” In “Liposomal (Ed. S.P. Vyas)”, CBS
4. Ambikanandan Misra (Author), Drug Delivery to the Central Nervous System, CBS
5. Ambikanandan Misra, “Tablets.” In “Pharmaceutical Product Development” (Ed. N. K.
Jain) CBS Publishers and Distributors, New Delhi, 2005, pp. 61-112.
6. Ambikanandan Misra Viral Jogani,& Pranav Shah, “Role of Herbal Absorption
Promoters in Oral Delivery of Therapeutics” In book series “Recent Progress in Medicinal Plants” Volume 14 (Biopharmaceuticals) Chapter 27, page 503-536, 2006.
7. Ambikanandan Misra, “Tablets.” In “Pharmaceutical Product Development” (Ed. N. K.
Jain) CBS Publishers and Distributors, New Delhi, 2006, pp. 61-112.
8. Ambikanadan Misra, "Drug delivery through the blood brain barrier" In “Exploring
9. Ambikanandan Misra, Manisha Lalan, 'Surfactants and Block Co-Polymers in Drug
Delivery' In “Colloids in Pharmaceutical and Biotechnological Applications”.In Press 10.Ambikanandan Misra, Tapan Shah, Kiruba Florence, ' 'Microemulsions in
Pharmaceuticals and Biotechnology'' In “Colloids in Pharmaceutical and Biotechnological Applications”. In Press 11.Ambikanandan Misra and Manisha S. Lalan , “Role of Natural
Polysaccharides in Treatment and Control of Diabetes” Vol. 25 , Recent Progress in Medicinal Plants. In Press.
PROFESSIONAL AFFILIATIONS
1) Life Member, Indian Pharmaceutical Association.
2) Life Member, Association of Pharmacy Teachers of India.
3) Ordinary Member, Controlled Release Society, India Chapter.
4) Ordinary Member, Indian Society of Technical Education.
5) Life Member of M.S.U. Pharmacy Alumni Association. POSITION HELD
1) Vice President, Indian Pharmaceutical Association, Baroda Branch (2000 Onwards) 2) Secretary, Indian Pharmaceutical Association, Baroda Branch (1997 to 2000)3) Joint Secretary, Indian Pharmaceutical Association, Baroda Branch (1991 to 1997) 4) Member Executive Committee, Association of Pharmacy Teachers of India (1995 to 5) Treasurer, M.S.U. Pharmacy Alumni Association (1997 to 2000)6) Member Executive Committee, Indian Society of Technical Education, Baroda Chapter

Source: http://www.msubaroda.ac.in/techo/upload/ANM.pdf

Nebenwirkungen einer hormonblockade vorbeugen

Wie den Nebenwirkungen einer Hormonblockade vorgebeugt werden kann (Preventing the side effects of hormone blockade) Von Prostate Oncology Specialists1), Marina del Rey, Kalifornien, übersetzt von Ralf-Rainer Damm, Dieburg, August 2003, überarbeitet November 2005 Eine Hormonblockade, das Vermindern oder Unterdrücken des Testosterons, ist die einzige Therapie bei Prostatakrebs, von der in

Copyright © 2012-2014 Medical Theses